David Templeton

David Templeton

Technik-/Wissenschafts-/F&E-Leiter bei N4 PHARMA PLC

Vermögen: - $ am 30.04.2024

Health Technology
Commercial Services

Ursprung des Netzwerks ersten Grades von David Templeton

EinheitArt der EinheitIndustrie
Public Company Biotechnology 5
1
Subsidiary Pharmaceuticals: Major 1

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von David Templeton

UnternehmenSektorVerknüpfte PersonenHauptposition
EISAI CO., LTD. Pharmaceuticals: Major

Gary Bryan Hendler

Corporate Officer/Principal

MEDISTEM INC Medical Specialties

John Chiplin

Director/Board Member

Pharmaceuticals: Major

John Chiplin

Director/Board Member

Miscellaneous Commercial Services

Luke Sebastian Cairns

Corporate Officer/Principal

LIONSGOLD LTD Precious Metals

Luke Sebastian Cairns

Director/Board Member

Pharmaceuticals: Major

John Chiplin

Director/Board Member

Investment Banks/Brokers

Luke Sebastian Cairns

Corporate Officer/Principal

TBG DIAGNOSTICS LIMITED Pharmaceuticals: Major

John Chiplin

President

Pharmaceuticals: Generic

Chris Britten

Corporate Officer/Principal

Pharmaceuticals: Major

Gary Bryan Hendler

Chairman

Miscellaneous Commercial Services

Paul Titley

Corporate Officer/Principal

POLYNOVO LIMITED Biotechnology

John Chiplin

Director/Board Member

Biotechnology

John Chiplin

Director/Board Member

Miscellaneous Commercial Services

John Chiplin

Chairman

The University of Southampton College/University

Nigel James Theobald

Undergraduate Degree

The University of Nottingham College/University

John Chiplin

Doctorate Degree

SEED INNOVATIONS LIMITED Investment Managers

Luke Sebastian Cairns

Director/Board Member

MANALTO LIMITED Packaged Software

John Chiplin

Director/Board Member

CYNATA THERAPEUTICS LIMITED Biotechnology

John Chiplin

Director/Board Member

Miscellaneous Commercial Services

Chris Britten

Director/Board Member

SCANCELL HOLDINGS PLC Biotechnology

John Chiplin

Chairman

Biotechnology

John Chiplin

Chief Executive Officer

Investment Managers

Luke Sebastian Cairns

Private Equity Investor

Miscellaneous Commercial Services

Chris Britten

Corporate Officer/Principal

Pharmaceuticals: Major

Chris Britten

Corporate Officer/Principal

Pharmaceuticals: Major

Gary Bryan Hendler

Chief Executive Officer

Pharmaceuticals: Major

Gary Bryan Hendler

Chief Executive Officer

Financial Conglomerates

John Chiplin

Director/Board Member

Investment Banks/Brokers

Luke Sebastian Cairns

Corporate Officer/Principal

Electronics Distributors

John Chiplin

Director/Board Member

SIENNA CANCER DIAGNOSTICS LIMITED Biotechnology

John Chiplin

Director/Board Member

ADALTA LIMITED Biotechnology

John Chiplin

Director/Board Member

Coma Research Institue

John Chiplin

Director/Board Member

Pharmaceuticals: Major

Nigel James Theobald

Director/Board Member

Investment Managers

Chris Britten

Corporate Officer/Principal

Newstar Ventures Ltd.

John Chiplin

Founder

LSC Advisory Ltd

Luke Sebastian Cairns

Founder

Financial Conglomerates

Luke Sebastian Cairns

Director/Board Member

Finance/Rental/Leasing

Luke Sebastian Cairns

Director/Board Member

Neuraxpharm UK Ltd.

Chris Britten

Corporate Officer/Principal

Packaged Software

John Chiplin

Chairman

Wholesale Distributors

Chris Britten

Chief Operating Officer

Movies/Entertainment

Luke Sebastian Cairns

Director/Board Member

Statistik

International

Vereinigtes Königreich 28
Vereinigte Staaten 9
Australien 9
Frankreich 3
Japan 2

Sektoral

Health Technology 22
Finance 13
Commercial Services 6
Consumer Services 4
Technology Services 3

Operativ

Director/Board Member 35
Corporate Officer/Principal 14
Independent Dir/Board Member 10
Chief Executive Officer 9
Chairman 9
  1. Börse
  2. Insiders
  3. David Templeton
  4. Unternehmensverbindungen